Should You Invest $1,000 in Eli Lilly today?
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The pharma giant's presence across several treatment areas has helped it grow earnings over time. But, in recent years, one particular product portfolio has stood out and driven double-digit revenue growth: drugs to help people lose weight.
Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 diabetes and as Zepbound for weight loss, though doctors have prescribed either one for patients hoping to shed pounds. Mounjaro and Zepbound each have become blockbusters, bringing in billion-dollar revenue annually. Lilly dominates the weight loss market along with rival Novo Nordisk, but a recent move by Lilly could help it push farther ahead in the coming years.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Considering this, should you invest $1,000 in Lilly stock today? Let's find out.
Lilly's weight loss drugs
So, first, let's talk about Lilly's path so far in this market and what might lie ahead. Lilly's weight loss drugs are part of a class known as dual GIP and GLP-1 receptor agonists. They act on hormonal pathways involved in the digestion process and help control blood sugar levels and appetite. Novo Nordisk's rival drug, semaglutide -- sold as Ozempic for type 2 diabetes and Wegovy for weight loss -- targets only GLP-1 but works in a similar way.
Novo Nordisk was first to market with its product, winning approval for Ozempic in 2017, and this offered it time to build a market-leading position. But demand has been so high for such weight loss drugs that Lilly quickly gained share soon after entering the market with Mounjaro in 2022 and then with Zepbound in 2023. In fact, demand has been so strong that these drugs held spots on the U.S. Food and Drug Administration's drug shortage list for quite some time, only exiting the list in recent months.
A better supply situation for weight loss drugs isn't due to a drop in demand but instead to increases in manufacturing capacity by both companies. So solid demand for these products still exists -- and is likely to grow.
Goldman cuts its market forecast
It's important to keep in mind, though, that both Lilly and rivals may face some headwinds in the years to come, and that's why Goldman Sachs Research recently reduced its forecast for global sales of anti-obesity medicines to $95 billion by 2030, from an earlier forecast of $130 billion. This is due to several potential challenges, including lower per-unit prices and weaker reimbursement from certain insurers.
But even considering the challenges, "we see a significant growth opportunity for both existing players as well as new entrants into this market," said Goldman analyst Asad Haider. After all, from today's $28 billion market, the forecast figure represents a 239% increase.
A look at Lilly's weight loss drug sales shows us this company has the momentum to benefit from this high-growth market. Last year, Mounjaro and Zepbound generated more than $11 billion and $4.9 billion in sales, respectively. And these two products are driving double-digit total sales growth at Lilly -- with a 32% gain in the full year and a 45% gain in the most recent quarter.
Now, what may push Lilly past Novo Nordisk -- and keep it far ahead of newer rivals down the road -- is the company's progress on an oral weight loss candidate. Current products are in injectable form, which may be less convenient and even uncomfortable for certain users. Lilly recently reported positive results from a phase 3 trial of its oral candidate, orforglipron, and plans to request approval for use in weight management by the end of the year. Though Novo Nordisk sells an oral form of semaglutide, it involves strict food and water guidelines. The potential Lilly product doesn't, offering it a significant advantage.
A look at valuation
Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward earnings estimates -- that's around the same level as top tech companies such as Amazon and Nvidia, also known for delivering double-digit revenue growth.
LLY PE Ratio (Forward) data by YCharts
In fact, since the launch of tirzepatide, Lilly has traded at valuations resembling those of growth stocks. So it may seem pricey to you for a pharmaceutical player.
But it's worth keeping in mind that Lilly stands out from the pharma crowd due to its presence in the high-growth market of weight loss drugs, yet at the same time it offers you the stability and dividend growth of a pharma stock. You generally can count on big pharma companies for steady revenue since patients always need their medicines -- regardless of the economic situation. And you can count on Lilly for passive income too, with a forward dividend of $6, representing a dividend yield of 0.8%.
Meanwhile, valuation has come down from its peak to levels that look very acceptable for a growth stock. All of this means that, by investing in Lilly, you're getting growth worthy of a tech company along with the safety generally associated with a pharma stock. That makes the stock well worth the price, and a great place to park $1,000 right now.
Should you invest $1,000 in Eli Lilly right now?
Before you buy stock in Eli Lilly, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!*
Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 2, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Adria Cimino has positions in Amazon. The Motley Fool has positions in and recommends Amazon, Goldman Sachs Group, and Nvidia. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Should You Buy Broadcom Stock Right Now?
Broadcom (NASDAQ: AVGO) reported quarterly financial results that demonstrated soaring demand for its AI products. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » *Stock prices used were the afternoon prices of June 4, 2025. The video was published on June 6, 2025. Should you invest $1,000 in Broadcom right now? Before you buy stock in Broadcom, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Broadcom wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. *Stock Advisor returns as of June 2, 2025 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
CTV News
an hour ago
- CTV News
How to get the most from a home inspection
Your bid just got accepted on the home you want, and suddenly there's so much to think about—the mortgage, the homeowners insurance, your move. As the clock ticks toward closing, your real estate agent hurries you along. In such a high-stakes rush, it may seem like a luxury to brake for a slo-mo walk through your future home as an inspector peers over rooftops, pokes at basement walls, and peeks into crawl spaces. But of all the things you need to get done, a home inspection should be at the top of the list. It's your one opportunity to have a trained professional diagnose the health of a home's mechanicals, structure, plumbing, roof, and all sorts of other components. It's a chance to get to know the house a little better before you fully commit. And the report the inspector produces gives you leverage to negotiate a lower price, or repairs, especially if costly issues turn up. For all those reasons, based on guidance from expert inspectors and real estate professionals contacted by Consumer Reports, we recommend that you make time to attend your home inspection, which typically takes two to four hours. You'll see firsthand what the issues are and also get a chance to really examine the house yourself. Some inspectors are fine with you attending the inspection for the whole time. Others prefer working alone for the first couple of hours so that they can concentrate and then have buyers come for a walk-through toward the end of the inspection. Either way, plan on being there. 'A home inspection is like a medical exam,' says Bob Acuff, owner of RE/MAX Services, a real estate brokerage based in Blue Bell, Pa. 'It's an education for the buyer about something very complicated. So take the time to ask the inspector questions, study the report you get afterward.' To make sure the precious few hours of your inspection pay off—not to mention the report itself—follow this advice from experienced home inspectors and real estate agents. What to know before you go Don't bring your kids or pets. This is definitely an instance where you'll want to drop off your little one at grandma's and leave your dog at home, because both you and the inspector need to be able to focus on the inspection. 'Having kids around is a distraction,' says Raymond Hogan, a home inspector and owner of Second Look Home Inspections in Cobden, Ill. Another concern: They could get hurt or accidentally break something. Wear the right footwear. This is no time for flip flops; wear sturdy closed-toe shoes. You want to be able to follow your inspector around wherever they go, and that may include muddy yards and damp basements. These areas could be where your inspector identifies the most troubling concerns, like water damage or a sinking foundation. During the inspection This is your chance to get an in-depth look at a place you may call home and ask all the questions you want. 'There are a lot of systems in a house to go over,' says Don Norman, a senior building consultant for BPG Inspections in Alpharetta, Ga. Do the following as you walk through the house: Take your time. 'Most people bid on a house after they've viewed it for 15 minutes,' Norman says. 'I've had people walk into a house and say they thought the dining room was in a different place. The inspection is a good time to look again and make sure the home is how you remember it.' Listen for hints of trouble. It's not the inspector's job to tell you whether to buy a home or bail. But during your time together, listen for clues, advises Gary Roholt, owner of A+ Inspection Specialists, based in Rice Lake, Wis. 'Listen for words and phrases like 'major,' 'significant,' 'immediate repair,' 'get estimates,' and 'needs to be fixed now,' ' he says. If you hear the words 'fungal material,' your inspector is talking about mould, but because of liability reasons, may not want to come out and say the word 'mould.' Your inspector should know local building codes and will let you know, both in person and in their report, when something in the house could be unsafe or is outright dangerous. 'If it's a safety issue, we're going to comment on it,' Norman says. If the inspector finds a significant concern and you really want their opinion on whether to steer clear of the home, frame your query in a way that doesn't put them on the spot. For instance, you could ask the inspector whether it would be a deal breaker for them or a family member, says Tina Marie Jung, a Realtor with RE/MAX Results in St. Louis, Mo., who represents buyers in half of her transactions. Jung says an inspector once told her client point-blank: 'I'd tell my daughter to walk away.' Note where key controls are. Pay attention when the inspector points out important components, such as the electrical breaker panel, the furnace emergency switch, and the water main shutoff. It will save you headaches later if, say, you need to turn off the water when an internal pipe bursts. The inspection report may include photos or even videos identifying those items, but you're more likely to remember them if you see them for yourself, Hogan says. Get referrals for other experts. Some home inspectors have specialized training or certification to inspect, say, artificial stucco or log homes. But they aren't experts in every building trade. Also, they can only point out problems they can see. Though an inspection report may indicate potential concerns with septic systems, pest infestations, radon, asbestos, water quality, and possible signs of mold, it's not meant to outline the entire scope of those problems. For that, you'll need experts who have specialized training in those fields. Your inspector will probably be able to recommend qualified specialists. You can also approach friends who've hired these professionals in the past for referrals, or check online reviews of specialists to home in on a candidate. Your inspector finds worrisome foundation cracks? You'll want a structural engineer or an architect to check it out more thoroughly. Does the house have a septic system? You'll want a septic-system testing company to come out and make sure it's in working order. Looking at a home that's 70 years or older? Consider hiring a plumber to use a 'sewer cam' — a big plumbing snake fitted with a video camera — to scope out blockages in the waste pipe that connects the home to the municipal system. 'In my area, a sewer cam costs US$175,' Jung says. 'But if the waste line turns out to need replacement, it could be $15,000 to $20,000 to jackhammer the sidewalk to get at it.' At the negotiating table Inspectors usually complete the report within a day or two. Once you have it in hand, task your real estate agent or attorney with presenting the items of concern to the seller for further negotiations. And if the inspector has mentioned specific issues that an expert should look at, don't be shy about telling the seller you need time to get those evaluations and estimates. Focus on major concerns. In your negotiations, bring up concerns that require remediation and repairs. There's often the most wiggle room for addressing problems with the major components of the home, such as the roof or HVAC, or concerns about radon or termites, Jung says. Bringing up minor concerns, though, may antagonize the seller. 'Stay away from mentioning the small nuts and bolts,' she says, 'the squeaky floors, missing locks on the door, the dishwasher needing to be replaced in a year.' Be firm on fixing safety and health threats. Sellers are more likely to negotiate on safety problems, such as a missing handrail on the stairs, especially if fixes are required for occupancy, says Jonathan Mernit, a real estate agent with Coldwell-Banker in Dobbs Ferry, N.Y. And health concerns that surface from further tests—like radon in basements—are a no-brainer, he adds. If the test comes back with results over the limit, the seller will have to remediate. 'The issue's going to come up with other buyers, so they're not going to say no,' he explains. Be open-minded about compensation. Keep in mind that you have more options than just asking for a lower price. For instance, you can ask the seller to give you a credit at the closing for the repair costs or see whether they will hire a professional to make the necessary repairs. Be realistic. If the seller agrees to repair or replace an item, don't expect her to pay for anything except the most basic work necessary, Jung warns. In a roof repair, for instance, you'll need to specify whether you want higher-quality shingles, and pay the price difference. 'The seller isn't going to give you the Cadillac of roofs,' Jung says. Be aware that your negotiating success may depend on whether the real estate market currently favors buyers or sellers. 'Seven or eight years ago, it was clearly a buyer's market where they were able to negotiate potentially thousands of dollars off for minor defects,' Acuff says. 'Sellers just wanted to get their house sold. That's not the market we're in today.' In fact, real estate agents told us, in a seller's market you could be competing with a buyer who doesn't require an inspection at all. In that case, you'll have to decide whether to back off your demands or walk away. 'Sometimes the best deal you do is the deal you don't do,' Acuff says. After your closing If you do buy the home, use the inspection report as a road map for repairs and maintenance. And don't be shy about contacting the inspector, even long after you've moved in. Norman notes that he doesn't charge anything to discuss his report—even years after the inspection—and in his experience, most home inspectors would do the same. By Tobie Stanger, Consumer Reports
Globe and Mail
an hour ago
- Globe and Mail
Apple Stock Gets Downgrade From Wall Street Analyst
The Wall Street analyst believes the shares are overvalued, given the headwinds Apple (NASDAQ: AAPL) faces. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » *Stock prices used were the afternoon prices of June 4, 2025. The video was published on June 6, 2025. Should you invest $1,000 in Apple right now? Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. *Stock Advisor returns as of June 2, 2025 Parkev Tatevosian, CFA has positions in Apple. The Motley Fool has positions in and recommends Apple. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
